Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Alphageneron Pharmaceuticals Logo
Alphageneron Pharmaceuticals CB Rank
947139
Heat Score
40
Alphageneron Pharmaceuticals is a biotechnology company that develops antibody drug conjugates and natural killer cell therapies.
Founded
obfuscation
Private Cambridge, Massachusetts, United States1-10 alphageneron.com/
Biotechnology
Medical
Therapeutics
Overview

Alphageneron Pharmaceuticals
Heat Score
40

Growth Score
pts
in past quarter
Heat Score 40
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Alphageneron Pharmaceuticals

CB Rank
947139
Alphageneron Pharmaceuticals is a biotechnology company that develops antibody drug conjugates and natural killer cell therapies.
Founded
obfuscation
Private Cambridge, Massachusetts, United States1-10 alphageneron.com/
Biotechnology
Medical
Therapeutics

Key People

  • Photo of A. Pockley
    A. Pockley: Chief Scientific Officer
    Past Role: Chromocyte, Founder & CEO

Details

Legal Name Alphageneron Pharmaceuticals Inc.
Operating Status Active
Company Type For Profit
Phone Number 1 (617) 520-6659
Contact Email info@alphageneron.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

ENKASTIM™ Autologous NK Cell Therapy
A therapy that activates a patient’s own natural killer (NK) cells to target cancers expressing membrane Hsp70, a cancer-specific biomarker.
AP-161™ Allogeneic NK Cell Therapy
An allogeneic NK cell therapy targeting tumors expressing membrane Hsp70, using activated NK cells from healthy donors without genetic modification.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News

News and Press

News•Jan 11, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

88

IT Spend

$49.8KThis year, Alphageneron Pharmaceuticals is projected to spend $49.8K on IT, according to Aberdeen.

Active Website Tech Count

3Alphageneron Pharmaceuticals is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, Google Maps, and  CommonCrawl Top 100m.
Sub-Organizations
Frequently Asked Questions

Where is Alphageneron Pharmaceuticals's headquarters? Alphageneron Pharmaceuticals is located in Cambridge, Massachusetts, United States.Who are Alphageneron Pharmaceuticals's competitors? Alternatives and possible competitors to Alphageneron Pharmaceuticals may include Artiva Biotherapeutics, ImmunityBio, and  Fate Therapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(55a1db1 1)
|